Annual Current Assets
$695.47 M
+$279.00 M+66.99%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual total current assets is $695.47 million, with the most recent change of +$279.00 million (+66.99%) on September 30, 2024.
- During the last 3 years, ARWR annual current assets has risen by +$310.87 million (+80.83%).
- ARWR annual current assets is now at all-time high.
Performance
ARWR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$695.47 M
+$245.41 M+54.53%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly total current assets is $695.47 million, with the most recent change of +$245.41 million (+54.53%) on September 30, 2024.
- Over the past year, ARWR quarterly current assets has increased by +$153.82 million (+28.40%).
- ARWR quarterly current assets is now at all-time high.
Performance
ARWR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ARWR Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +67.0% | +28.4% |
| 3 y3 years | +80.8% | +80.8% |
| 5 y5 years | +162.2% | +80.8% |
ARWR Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.8% | at high | +192.3% |
| 5 y | 5-year | at high | +162.2% | at high | +192.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Arrowhead Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $444.33 M(+27.3%) | $695.47 M(+54.5%) |
| Jun 2024 | - | $450.06 M(-16.9%) |
| Mar 2024 | - | $541.65 M(+127.7%) |
| Dec 2023 | - | $237.90 M(-42.9%) |
| Sep 2023 | $349.08 M(+21.8%) | $416.47 M(-11.4%) |
| Jun 2023 | - | $470.17 M(-18.2%) |
| Mar 2023 | - | $574.81 M(-0.0%) |
| Dec 2022 | - | $575.00 M(+41.9%) |
| Sep 2022 | $286.64 M(-12.0%) | $405.30 M(-6.3%) |
| Jun 2022 | - | $432.39 M(+3.5%) |
| Mar 2022 | - | $417.63 M(+23.5%) |
| Dec 2021 | - | $338.28 M(-12.0%) |
| Sep 2021 | $325.55 M(+62.7%) | $384.60 M(-26.9%) |
| Jun 2021 | - | $525.96 M(-10.4%) |
| Mar 2021 | - | $586.76 M(+81.3%) |
| Dec 2020 | - | $323.72 M(+0.4%) |
| Sep 2020 | $200.13 M(+136.6%) | $322.37 M(+2.3%) |
| Jun 2020 | - | $315.23 M(+0.2%) |
| Mar 2020 | - | $314.47 M(-38.0%) |
| Dec 2019 | - | $507.61 M(+91.4%) |
| Sep 2019 | $84.60 M(+157.6%) | $265.25 M(+8.5%) |
| Jun 2019 | - | $244.54 M(+4.1%) |
| Mar 2019 | - | $234.97 M(-5.6%) |
| Dec 2018 | - | $248.95 M(+216.1%) |
| Sep 2018 | $32.84 M(-9.1%) | $78.77 M(+27.3%) |
| Jun 2018 | - | $61.87 M(-33.2%) |
| Mar 2018 | - | $92.66 M(+74.5%) |
| Dec 2017 | - | $53.11 M(-21.8%) |
| Sep 2017 | $36.12 M(-4.1%) | $67.90 M(-12.8%) |
| Jun 2017 | - | $77.90 M(-13.1%) |
| Mar 2017 | - | $89.69 M(-15.6%) |
| Dec 2016 | - | $106.23 M(+17.4%) |
| Sep 2016 | $37.67 M(+28.2%) | $90.50 M(+82.5%) |
| Jun 2016 | - | $49.60 M(-25.0%) |
| Mar 2016 | - | $66.14 M(-19.6%) |
| Dec 2015 | - | $82.28 M(-20.0%) |
| Sep 2015 | $29.40 M(+4.9%) | $102.87 M(-10.3%) |
| Jun 2015 | - | $114.69 M(-4.5%) |
| Mar 2015 | - | $120.15 M(-9.1%) |
| Dec 2014 | - | $132.16 M(-14.6%) |
| Sep 2014 | $28.02 M(+230.1%) | $154.80 M(-5.3%) |
| Jun 2014 | - | $163.42 M(+0.9%) |
| Mar 2014 | - | $161.92 M(+111.9%) |
| Dec 2013 | - | $76.41 M(+164.9%) |
| Sep 2013 | $8.49 M(-14.8%) | $28.84 M(-16.2%) |
| Jun 2013 | - | $34.41 M(+820.1%) |
| Mar 2013 | - | $3.74 M(-38.3%) |
| Dec 2012 | - | $6.06 M(-7.7%) |
| Sep 2012 | $9.96 M | $6.57 M(+11.3%) |
| Jun 2012 | - | $5.90 M(-33.1%) |
| Mar 2012 | - | $8.82 M(-3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $9.17 M(-7.0%) |
| Sep 2011 | $6.03 M(+42.7%) | $9.86 M(+39.9%) |
| Jun 2011 | - | $7.05 M(-17.9%) |
| Mar 2011 | - | $8.58 M(-22.3%) |
| Dec 2010 | - | $11.04 M(+35.8%) |
| Sep 2010 | $4.22 M(-19.1%) | $8.13 M(-19.7%) |
| Jun 2010 | - | $10.13 M(+238.6%) |
| Mar 2010 | - | $2.99 M(-27.9%) |
| Dec 2009 | - | $4.15 M(+67.0%) |
| Sep 2009 | $5.22 M(-22.0%) | $2.48 M(-9.8%) |
| Jun 2009 | - | $2.75 M(-34.1%) |
| Mar 2009 | - | $4.18 M(-53.7%) |
| Dec 2008 | - | $9.02 M(-14.6%) |
| Sep 2008 | $6.69 M(+47.2%) | $10.56 M(-27.4%) |
| Jun 2008 | - | $14.54 M(-29.2%) |
| Mar 2008 | - | $20.55 M(-21.6%) |
| Dec 2007 | - | $26.21 M(+3.6%) |
| Sep 2007 | $4.55 M(-20.9%) | $25.31 M(-21.2%) |
| Jun 2007 | - | $32.11 M(+42.7%) |
| Mar 2007 | - | $22.49 M(-21.9%) |
| Dec 2006 | - | $28.81 M(+0.1%) |
| Sep 2006 | $5.75 M(-7.7%) | $28.78 M(-8.2%) |
| Jun 2006 | - | $31.34 M(-13.2%) |
| Mar 2006 | - | $36.11 M(+85.0%) |
| Dec 2005 | - | $19.52 M(-14.4%) |
| Sep 2005 | $6.23 M(+157.4%) | $22.81 M(-11.1%) |
| Jun 2005 | - | $25.66 M(+164.5%) |
| Mar 2005 | - | $9.70 M(+32.7%) |
| Dec 2004 | - | $7.31 M(-23.0%) |
| Sep 2004 | $2.42 M(>+9900.0%) | $9.50 M(-13.2%) |
| Jun 2004 | - | $10.94 M(-4.9%) |
| Mar 2004 | - | $11.50 M(+440.9%) |
| Dec 2003 | - | $2.13 M(+40.4%) |
| Sep 2003 | $2000.00(-93.6%) | $1.51 M(+7546.0%) |
| Jun 2003 | - | $19.80 K(+30.3%) |
| Mar 2003 | - | $15.20 K(-15.6%) |
| Dec 2002 | - | $18.00 K(-43.9%) |
| Sep 2002 | $31.40 K(+7750.0%) | $32.10 K(-53.9%) |
| Jun 2002 | - | $69.70 K(+44.9%) |
| Mar 2002 | - | $48.10 K(-0.2%) |
| Dec 2001 | - | $48.20 K(+5.0%) |
| Sep 2001 | $400.00(-99.2%) | $45.90 K(-20.9%) |
| Jun 2001 | - | $58.00 K(-0.5%) |
| Mar 2001 | - | $58.30 K(+288.7%) |
| Dec 2000 | - | $15.00 K(-6.8%) |
| Sep 2000 | $49.10 K(-12.2%) | $16.10 K(-0.6%) |
| Jun 2000 | - | $16.20 K(-4.1%) |
| Mar 2000 | - | $16.90 K(+6.3%) |
| Dec 1999 | - | $15.90 K |
| Sep 1999 | $55.90 K(-12.8%) | - |
| Sep 1998 | $64.10 K(-12.9%) | - |
| Sep 1997 | $73.60 K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual current assets year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly current assets year-on-year change?
What is Arrowhead Pharmaceuticals annual total current assets?
The current annual current assets of ARWR is $695.47 M
What is the all time high annual current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total current assets is $695.47 M
What is Arrowhead Pharmaceuticals annual current assets year-on-year change?
Over the past year, ARWR annual total current assets has changed by +$279.00 M (+66.99%)
What is Arrowhead Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ARWR is $695.47 M
What is the all time high quarterly current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total current assets is $695.47 M
What is Arrowhead Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ARWR quarterly total current assets has changed by +$153.82 M (+28.40%)